The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet

被引:41
作者
Chen, W [1 ]
Matuda, K
Nishimura, N
Yokogoshi, H
机构
[1] Univ Shizuoka, Lab Natl Biochem, Sch Food & Nutrit Sci, Shizuoka 4228526, Japan
[2] Nayoro City Coll, Dept Human Life & Dev, Nayoro 0968641, Japan
关键词
taurine; cholesterol; LDL receptor; triglycerides (TG) secretion; mice;
D O I
10.1016/j.lfs.2003.08.041
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The hypocholesterolemic effect of taurine was examined in mice fed a high-cholesterol diet containing 1% cholesterol and 0.25% sodium cholate. Male C57BL/6 mice were divided into 3 groups: control group (HC), 1% taurine-supplemented group (HCT+), and taurine-deficient group (HCT-) produced by supplying 0.5% guanidinoethyl sulfonate (GES) solution ad libitum instead of water. After they were fed with the respective diet or drinking water for 4 weeks, the liver taurine level was reduced 80% in the HCT - group compared with that in the HC group, although there was no difference in the serum taurine amount between the two groups. The formation ratio of cholesterol gallstones increased from 71% to 100% by taurine deficiency, and decreased to 0% by taurine supplementation. Compared with the HC group, serum and liver cholesterol significantly decreased, and the excretion of fecal bile acid notably rose in the HCT+ group but tended to lower in the HCT - group. There were no differences in LDL receptor protein level among the three groups. In the subsequent experiment, triglycerides (TG) secretion rate was determined and found to be significantly suppressed by taurine supplementation. In conclusion, it is suggested that taurine does not up-regulate LDL receptor protein level, and the decrease in cholesterol in the circulation is mainly due to its suppressive effect on TG secretion from the liver. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1889 / 1898
页数:10
相关论文
共 25 条
[1]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[2]  
COSGROVE PG, 1993, J LIPID RES, V34, P1983
[3]  
DANIELSSON H, 1963, ADV LIPID RES, V1, P335
[4]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[5]  
HARDISON WGM, 1977, P SOC EXP BIOL MED, V155, P55
[6]   PHYSIOLOGICAL ACTIONS OF TAURINE [J].
HUXTABLE, RJ .
PHYSIOLOGICAL REVIEWS, 1992, 72 (01) :101-163
[7]  
HUXTABLE RJ, 1979, J PHARMACOL EXP THER, V211, P465
[8]  
KURIYAMA K, 1980, FED PROC, V39, P2680
[9]  
Li XH, 1996, J LIPID RES, V37, P210
[10]  
MASUDA M, 1986, J PHARMACOBIO-DYNAM, V9, P934